Section Editors
- Paolo Bruzzi, National Cancer Research Institute
- Carlos Caldas, Cambridge Research Institute
- Ian Cree, Warwick Medical School, Coventry
- Shoukat Dedhar, British Columbia Cancer Agency
- John A Hartley, University College London
- Manami Inoue, University of Tokyo
- Mark McKeage, University of Auckland
- Christophe Nicot, Kansas University Medical Center
- Stephen P Povoski, The Ohio State University
- Dirk Vordermark, Martin Luther University Halle-Wittenberg
Executive Editor
- Dafne Solera, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Cancer 2013, 13:400Targeting microspheres to mesothelioma
Silica microparticles loaded with doxorubicin (DOX) and modified with a mesothelin specific antibody demonstrate higher effectiveness and lower toxicity than DOX systemic treatment in a mouse xenograft model of human peritoneal mesothelioma.
-
BMC Cancer 2013, 13:355Multidisciplinary approach to cancer
Newly appointed Section Editor Stephen Povoski and Deputy Nathan Hall comment on plans to expand the scope of the BMC Cancer Clinical Oncology section, as surgical oncology and cancer imaging join forces with chemotherapy and radiation.
-
BMC Cancer 2013, 13:344Biomarkers from the breast fluid secretome
Ferdinando Mannello and Daniela Ligi review breast cancer biomarkers that mirror the tumor microenvironment and discuss the potential of the nipple aspirate fluid secretome as a source of novel markers for early detection.
-
BMC Cancer 2013, 13:197When the helpers hinder
When exposed to factors secreted from tumour cells, macrophages and monocytes release EGFR ligands and STAT3 activators to promote macrophage infiltration, tumour growth and dissemination in invasive breast cancer.
- View more articles
Hot topic
Research article
Nrf2 is required to maintain the self-renewal of glioma stem cells
BMC Cancer 2013, 13:380
News from the web
- 30 September 2013
- Use of <I>SHOX2</I> DNA measurement improves cancer staging tools
- 30 September 2013
- Intercalated erlotinib/chemotherapy shows mixed results in NSCLC
- 27 September 2013
- Time to first cigarette independently predicts lung cancer
Scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Cancer and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmccancer@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
Latest review
Functional significance of erythropoietin in renal cell carcinoma
Christudas Morais, David W Johnson, David A Vesey, and Glenda C Gobe1
BMC Cancer 2013, 13:14 (10 January 2013)Section Editor's profile
Mark McKeage is a medical oncologist and associate professor in the department of pharmacology and clinical pharmacology and co-director of the Auckland Cancer Society Research Centre at the university of Auckland, New Zealand. His current research focuses on how membrane transporters determine response and handling of platinum-based anticancer drugs. In addition, he leads a programme of phase I oncology trials at his centre.
"BMC Cancer is the leading Open Access international journal in the field of oncology. By publishing over 500 articles per year, BMC Cancer offers rapid dissemination of the most recent information of interest to the broad oncology science community."
Prof McKeage is the Section Editor of the Clinical oncology- medical oncology and pharmacology section of BMC Cancer.
BMC series blog
- 25 September 2013
- BMC and the Royal College of General Practitioners
- 19 September 2013
- Enhancing sexual health services through E-health technology
Article Series
Cancer bioinformatics
Published: 1 May 2012
Email updates
Receive periodic news and updates relating to BioMed Central straight to your inbox.
Indexed by
- CAS
- Cases Database
- DOAJ
- Embase
- MEDLINE
- PubMed
- Science Citation Index Expanded
- Scopus


RSS
Comments
View more comments